Literature DB >> 8961377

Evaluation of interleukin-6 in rheumatoid arthritis as an activity criterion.

T Sentürk1, G Kinikli, M Turgay, H Tutkak, M Duman, G Tokgöz.   

Abstract

This study evaluated interleukin-6 levels as an activity criterion in rheumatoid arthritis (RA) and compared if with other activity criteria. We evaluated 35 patients with active RA, 31 with inactive RA, and 25 patients with osteoarthritis, in addition to 28 healthy individuals. Serum interleukin-6 levels were higher in active RA patients than in those with inactive RA, or osteoarthritis and healthy individuals (P < 0.001). Serum interleukin-6 levels of patients with active RA were positively correlated with the erythrocyte sedimentation rate, C-reactive protein, and alpha 2-globulin levels (P < 0.001), but there was a negative correlation with serum albumin levels (P < 0.05). We conclude that interleukin-6 can be responsible for both the most systemic manifestations of RA and for its local manifestations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961377     DOI: 10.1007/bf01419726

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

Review 1.  A multifunctional cytokine (IL-6/BSF-2) and its receptor.

Authors:  T Hirano; T Taga; K Yamasaki; T Matsuda; B Tang; A Muraguchi; Y Horii; S Suematsu; Y Hirata; H Yawata
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

Review 2.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).

Authors:  S Akira; T Hirano; T Taga; T Kishimoto
Journal:  FASEB J       Date:  1990-08       Impact factor: 5.191

3.  IL-6/IFN-beta 2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources.

Authors:  N Bhardwaj; U Santhanam; L L Lau; S B Tatter; J Ghrayeb; M Rivelis; R M Steinman; P B Sehgal; L T May
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

4.  IL-1 stimulates IL-6 production in endothelial cells.

Authors:  M Sironi; F Breviario; P Proserpio; A Biondi; A Vecchi; J Van Damme; E Dejana; A Mantovani
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

5.  Production and modulation of interleukin 6 synthesis by synoviocytes derived from patients with arthritic disease.

Authors:  J T Rosenbaum; R Cugnini; D C Tara; S Hefeneider; J C Ansel
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

6.  Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera.

Authors:  M Helle; L Boeije; E de Groot; A de Vos; L Aarden
Journal:  J Immunol Methods       Date:  1991-04-08       Impact factor: 2.303

Review 7.  Interleukin-6 and its receptor during homeostasis, inflammation, and tumor growth.

Authors:  J Bauer
Journal:  Klin Wochenschr       Date:  1989-07-17

8.  Interleukin-6 activity in paired samples of synovial fluid. Correlation of synovial fluid interleukin-6 levels with clinical and laboratory parameters of inflammation.

Authors:  A M Miltenburg; J M van Laar; R de Kuiper; M R Daha; F C Breedveld
Journal:  Br J Rheumatol       Date:  1991-06

Review 9.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

10.  Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts.

Authors:  P L Tan; S Farmiloe; S Yeoman; J D Watson
Journal:  J Rheumatol       Date:  1990-12       Impact factor: 4.666

View more
  1 in total

1.  Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis.

Authors:  Hae-Rim Kim; Kyoung-Woon Kim; So-Young Yoon; Sang-Hyon Kim; Sang-Heon Lee
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.